IP Library › Granted Patent US 8,722,060
Granted Patent B2
US 8,722,060 · App. 13/478,640 · Granted May 13, 2014

Method of treating vertigo

Inventor: William J. Binder (Beverly Hills, CA)
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,722,060
App. No.
13/478,640
Granted
May 13, 2014
Kind
B2
Abstract

The invention is a method for reducing the symptoms of vertigo. The method is performed by delivering a therapeutically effective amount of presynaptic neurotoxin, such as Botulinum Toxin A, in a pharmaceutically safe form to suitable locations around the head and neck.

Claims (5)

1. The method for treating Migraine Associated Vertigo comprising administering to a human having Migraine Associated Vertigo a therapeutically effective amount of a presynaptic neurotoxin in a pharmaceutically safe form.

2. The method according to claim 1 wherein the presynaptic neurotoxin is a Botulinum toxin.

3. The method according to claim 2 wherein the Botulinum toxin is Botulinum toxin A.

4. The method according to claim 2 wherein the Botulinum toxin is Botulinum toxin B.

5. The method according to claim 3 wherein the botulinum toxin A is onabotulinumtoxinA.

Assignments (3)
SECURITY INTEREST Recorded Dec 22, 2023
From: MIOTOX, LLC
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 065940/0196 →
SECURITY INTEREST Recorded Aug 14, 2019
From: MIOTOX, LLC
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 050057/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 11, 2014
From: BINDER, WILLIAM J.
To: MIOTOX, LLC
Reel/Frame 032816/0988 →
Continuity (1)
Related Publication 20130315957A1 · Nov 28, 2013